TickerFacts.

Polomar Health Services, Inc. (PMHS): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$1.22M
As of 2025-12-31
-$1.06M
As of 2026-06-30
$8.60M2022-12-31: $186.8K2023-12-31: -$44.5K2024-12-31: $8.60M2025-12-31: -$1.22M-$1.22M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$1.22Mn/m2026-05-06, Balance as of period end
2024-12-31$8.60Mn/m2026-05-06, Balance as of period end
2023-12-31-$44.5Kn/m2025-05-22, Balance as of period end
2022-12-31$186.8Kn/a2024-04-15, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Polomar Health Services, Inc. (PMHS)2025-12-31-$1.22Mn/m
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31-$95.46Mn/m
Vaccinex, Inc. (VCNX)2024-12-31-$2.49Mn/m
Lexaria Bioscience Corp. (LEXX)2025-08-31$2.99M-62.8%
PMGC Holdings Inc. (ELAB)2025-12-31$7.84M+17.7%
Yarrow Bioscience, Inc. (YARW)2025-12-31$27.77M-46.7%
Silence Therapeutics plc (SLN)2025-12-31$62.30M-53.5%
Quantum Cyber N.V. (QUCY)2025-12-31$641.6K-89.3%
Lipella Pharmaceuticals Inc. (LIPO)2024-12-31$1.92M-39.0%

Compare PMHS, BTAIQ, VCNX, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗